Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
03-2017 | 03-2016 | 03-2015 | 03-2014 | 03-2013 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 39,040 | 48,231 | 22,401 | 20,916 | 9,451 |
Marketable Securities | 190,908 | 163,822 | 109,557 | 55,663 | 67,256 |
Receivables | 54,055 | 42,821 | 31,828 | 24,357 | 22,946 |
Inventories | 34,931 | 26,740 | 16,774 | 13,948 | 14,930 |
TOTAL | $326,958 | $288,392 | $185,039 | $117,966 | $116,605 |
Non-Current Assets | |||||
PPE Net | 87,777 | 23,184 | 9,127 | 6,889 | 6,549 |
Investments And Advances | 47,143 | 1,000 | 13,996 | 41,761 | 11,406 |
Intangibles | 31,045 | 33,003 | 31,534 | 37,990 | 35,410 |
Other Non-Current Assets | 57,491 | 78,352 | 98,671 | 801 | 29 |
TOTAL | $223,456 | $135,539 | $153,328 | $87,441 | $53,394 |
Total Assets | $550,414 | $423,931 | $338,367 | $205,407 | $169,999 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 20,620 | 9,381 | 10,389 | 7,746 | 7,696 |
Accrued Expenses | 37,703 | 28,382 | 21,894 | 17,899 | 15,162 |
TOTAL | $69,617 | $46,541 | $39,319 | $30,411 | $27,056 |
Non-Current Liabilities | |||||
Deferred Revenues | 10,495 | 8,778 | 7,036 | 4,766 | 4,198 |
Other Non-Current Liabilities | 12,404 | 7,783 | 6,693 | 6,643 | 309 |
TOTAL | $28,726 | $8,615 | $7,488 | $6,643 | $5,863 |
Total Liabilities | $98,343 | $55,156 | $46,807 | $37,054 | $32,919 |
Shareholders' Equity | |||||
Shares Outstanding, K | 43,819 | 42,735 | 41,737 | 39,927 | 38,735 |
Common Shares | 437 | 426 | 413 | 411 | 397 |
Retained earnings | -46,959 | -99,075 | -137,222 | -250,910 | -258,261 |
Other shareholders' equity | -20,369 | -14,200 | -17,677 | -284 | -3,866 |
TOTAL | $452,071 | $368,775 | $291,560 | $168,353 | $137,080 |
Total Liabilities And Equity | $550,414 | $423,931 | $338,367 | $205,407 | $169,999 |